Goodwin Procter, McDermott Will & Emery, and Mason Hayes & Curran advised LetsGetChecked, while Latham & Watkins and BakerHostetler advised Truepill on the deal. LetsGetChecked, a...
LetsGetChecked’s Acquisition of Truepill
AbbVie’s Acquisition of Cerevel Therapeutics
Kirkland & Ellis advised AbbVie, Latham & Watkins advised Cerevel Therapeutics, Skadden advised Centerview partners LLC, as financial advisor to Cerevel Therapeutics in the transaction. AbbVie...
Eclipse’ US$31.4 Million Series B Investment in Capstan Medical
Latham & Watkins advises Eclipse on investment in Capstan Medical. Capstan Medical, a developer of minimally invasive technology to address heart valve disease, closed an oversubscribed...
Switch, Inc.’s Obtain Dismissal With Prejudice of Stockholder Class Action Complaint
Latham Secures Dismissal With Prejudice of Stockholder Class Action Complaint for Switch, Inc. Challenging US$11 Billion Take-Private Transaction. A Southern-California Latham securities litigation team earned a...
Merck’s Acquisition of Prometheus Biosciences
Paul, Weiss, Rifkind, Wharton & Garrison represented Merck, Latham & Watkins represented Prometheus, Skadden represented the financial advisors on the deal. Prometheus Biosciences, Inc. have entered...
Bausch + Lomb’s Acquisition of AcuFocus
Latham & Watkins LLP represented AcuFocus in the transaction. Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see...
DigitalBridge Investment Management and IFM’s $11 Billion Take-Private Acquisition of Switch
Latham & Watkins advised the Special Committee of the Board of Directors of Switch, and Simpson Thacher & Bartlett advised DigitalBridge and IFM on the deal....
Ligand’s Spin-off of OmniAb Business
Latham & Watkins represented Ligand in the transaction, while Weil, Gotshal & Manges represented APAC. Ligand Pharmaceuticals Incorporated has announced the signing of a definitive merger...
UCB’s Acquisition of Zogenix
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...
Waldencast’s $1.2 Billion Business Combination With Obagi and Milk Makeup
Skadden, Arps, Slate, Meagher & Flom represented Waldencast. Latham & Watkins, working alongside Conyers and Nixon Peabody, represented Obagi, and Goodwin Procter represented Milk Makeup in...
General Atlantic’s US$80 Million Equity Investment in Vegamour
Sidley Austin LLP advised Vegamour on the deal, while Paul, Weiss advised General Atlantic. Vegamour obtained an US$80 million equity investment by General Atlantic. Vegamour is a...